Advertisement

Index by Author

August 1989; 38 (8)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Avogaro, A

    • Stable-label intravenous glucose tolerance test minimal model. Diabetes August 1989 38:1048-1055; doi:10.2337/diabetes.38.8.1048

B

  1. Baba, S

    • Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes August 1989 38:1042-1047; doi:10.2337/diabetes.38.8.1042

  2. Basalyga, B S

    • In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes August 1989 38:1036-1041; doi:10.2337/diabetes.38.8.1036

  3. Bell, G I

    • Disease associations. Chance, artifact, or susceptibility genes? Diabetes August 1989 38:947-950; doi:10.2337/diabetes.38.8.947
    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

  4. Bier, D M

    • Stable-label intravenous glucose tolerance test minimal model. Diabetes August 1989 38:1048-1055; doi:10.2337/diabetes.38.8.1048

  5. Black, S C

    • Cardiac performance and plasma lipids of omega-3 fatty acid-treated streptozocin-induced diabetic rats. Diabetes August 1989 38:969-974; doi:10.2337/diabetes.38.8.969

  6. Bortolami, M C

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  7. Bose, P

    • In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes August 1989 38:1036-1041; doi:10.2337/diabetes.38.8.1036

  8. Brady, D

    • Decreased activation rate of insulin-stimulated glucose transport in adipocytes from obese subjects. Diabetes August 1989 38:991-995; doi:10.2337/diabetes.38.8.991

  9. Bristow, J D

    • Stable-label intravenous glucose tolerance test minimal model. Diabetes August 1989 38:1048-1055; doi:10.2337/diabetes.38.8.1048

  10. Buchanan, T A

    • Lack of teratogenic effect of brief maternal insulin-induced hypoglycemia in rats during late neurulation. Diabetes August 1989 38:1063-1066; doi:10.2337/diabetes.38.8.1063

  11. Byers, M G

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

C

  1. Chakrabarti, S

    • Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes August 1989 38:1067-1071; doi:10.2337/diabetes.38.8.1067

  2. Chiba, T

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

  3. Ciaraldi, T P

    • Neuraminidase treatment of isolated rat adipocytes and differential regulation of basal and insulin-stimulated glucose transport. Diabetes August 1989 38:951-958; doi:10.2337/diabetes.38.8.951
    • Decreased activation rate of insulin-stimulated glucose transport in adipocytes from obese subjects. Diabetes August 1989 38:991-995; doi:10.2337/diabetes.38.8.991

  4. Cobelli, C

    • Stable-label intravenous glucose tolerance test minimal model. Diabetes August 1989 38:1048-1055; doi:10.2337/diabetes.38.8.1048

  5. Cogswell, B E

    • Tyrosine hydroxylase activity in sympathetic nervous system of rats with streptozocin-induced diabetes. Diabetes August 1989 38:959-968; doi:10.2337/diabetes.38.8.959

  6. Cox, N J

    • Disease associations. Chance, artifact, or susceptibility genes? Diabetes August 1989 38:947-950; doi:10.2337/diabetes.38.8.947

D

  1. Damjanov, I

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

  2. Daniels, B S

    • Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes August 1989 38:981-986; doi:10.2337/diabetes.38.8.981

  3. Di Giamberardino, L

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  4. Donà, M

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  5. Dunlap, J A

    • Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells. Diabetes August 1989 38:996-1004; doi:10.2337/diabetes.38.8.996

E

  1. Eddy, R L

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

  2. Eifler, C W

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

F

  1. Fabris, M

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  2. Fan, Y S

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

  3. Fiori, M G

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  4. Frazier, M L

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

G

  1. Ghahary, A

    • Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes August 1989 38:1067-1071; doi:10.2337/diabetes.38.8.1067

  2. Gilligan, A

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

  3. Gong, Y W

    • Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes August 1989 38:1067-1071; doi:10.2337/diabetes.38.8.1067

  4. Grunfeld, C

    • Peptide-based radioimmunoassay for insulin receptor. Detection of insulin-stimulated downregulation in IM-9 lymphocytes. Diabetes August 1989 38:987-990; doi:10.2337/diabetes.38.8.987

  5. Guidolin, D

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

H

  1. Haffner, S M

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

  2. Hazuda, H P

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

  3. Hindson, D A

    • Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes August 1989 38:1031-1035; doi:10.2337/diabetes.38.8.1031

  4. Hostetter, T H

    • Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes August 1989 38:981-986; doi:10.2337/diabetes.38.8.981

I

  1. Ito, A

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

J

  1. Jewett, L

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

K

  1. Kassm, H M

    • In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes August 1989 38:1036-1041; doi:10.2337/diabetes.38.8.1036

  2. Katz, S

    • Cardiac performance and plasma lipids of omega-3 fatty acid-treated streptozocin-induced diabetic rats. Diabetes August 1989 38:969-974; doi:10.2337/diabetes.38.8.969

  3. Kayano, T

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

  4. Kikkawa, U

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

  5. Knowles, B B

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

L

  1. Leeney, E M

    • Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells. Diabetes August 1989 38:996-1004; doi:10.2337/diabetes.38.8.996

  2. Luo, J M

    • Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes August 1989 38:1067-1071; doi:10.2337/diabetes.38.8.1067

M

  1. Marini, P

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  2. Matschinsky, F M

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

  3. McFarland, K C

    • Peptide-based radioimmunoassay for insulin receptor. Detection of insulin-stimulated downregulation in IM-9 lymphocytes. Diabetes August 1989 38:987-990; doi:10.2337/diabetes.38.8.987

  4. McNeill, J H

    • Cardiac performance and plasma lipids of omega-3 fatty acid-treated streptozocin-induced diabetic rats. Diabetes August 1989 38:969-974; doi:10.2337/diabetes.38.8.969

  5. Mitchell, B D

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

  6. Molina, J M

    • Decreased activation rate of insulin-stimulated glucose transport in adipocytes from obese subjects. Diabetes August 1989 38:991-995; doi:10.2337/diabetes.38.8.991

  7. Murphy, L J

    • Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes August 1989 38:1067-1071; doi:10.2337/diabetes.38.8.1067

  8. Murray, J C

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

N

  1. Nakamura, Y

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

  2. Nielson, C P

    • Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes August 1989 38:1031-1035; doi:10.2337/diabetes.38.8.1031

O

  1. Ohki, A

    • Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes August 1989 38:1042-1047; doi:10.2337/diabetes.38.8.1042

  2. Okabayashi, Y

    • Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes August 1989 38:1042-1047; doi:10.2337/diabetes.38.8.1042

  3. Olefsky, J M

    • Decreased activation rate of insulin-stimulated glucose transport in adipocytes from obese subjects. Diabetes August 1989 38:991-995; doi:10.2337/diabetes.38.8.991

  4. Otsuki, M

    • Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes August 1989 38:1042-1047; doi:10.2337/diabetes.38.8.1042

P

  1. Paro, M

    • Autonomic neuropathy in BB rats and alterations in bladder function. Diabetes August 1989 38:1023-1030; doi:10.2337/diabetes.38.8.1023

  2. Pinkert, C

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

  3. Prosdocimi, M

    • Autonomic neuropathy in BB rats and alterations in bladder function. Diabetes August 1989 38:1023-1030; doi:10.2337/diabetes.38.8.1023

R

  1. Raboudi, S H

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

  2. Ramachandran, J

    • Peptide-based radioimmunoassay for insulin receptor. Detection of insulin-stimulated downregulation in IM-9 lymphocytes. Diabetes August 1989 38:987-990; doi:10.2337/diabetes.38.8.987

S

  1. Saitoh, Y

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

  2. Saito, N

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

  3. Schiavinato, A

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

  4. Schmidt, R E

    • Tyrosine hydroxylase activity in sympathetic nervous system of rats with streptozocin-induced diabetes. Diabetes August 1989 38:959-968; doi:10.2337/diabetes.38.8.959

  5. Shows, T B

    • Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13. Diabetes August 1989 38:1072-1075; doi:10.2337/diabetes.38.8.1072

  6. Sima, A A

    • Autonomic neuropathy in BB rats and alterations in bladder function. Diabetes August 1989 38:1023-1030; doi:10.2337/diabetes.38.8.1023
    • Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes August 1989 38:1067-1071; doi:10.2337/diabetes.38.8.1067

  7. Simon, D

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

  8. Sipos, G F

    • Lack of teratogenic effect of brief maternal insulin-induced hypoglycemia in rats during late neurulation. Diabetes August 1989 38:1063-1066; doi:10.2337/diabetes.38.8.1063

  9. Staretz, M E

    • In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes August 1989 38:1036-1041; doi:10.2337/diabetes.38.8.1036

  10. Stern, M P

    • Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes August 1989 38:975-980; doi:10.2337/diabetes.38.8.975

  11. Sutherland, G

    • Autonomic neuropathy in BB rats and alterations in bladder function. Diabetes August 1989 38:1023-1030; doi:10.2337/diabetes.38.8.1023

T

  1. Tanaka, C

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

  2. Taniguchi, H

    • Localization of beta II subspecies of protein kinase C in beta-cells. Diabetes August 1989 38:1005-1011; doi:10.2337/diabetes.38.8.1005

  3. Tani, S

    • Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes August 1989 38:1042-1047; doi:10.2337/diabetes.38.8.1042

  4. Toffolo, G

    • Stable-label intravenous glucose tolerance test minimal model. Diabetes August 1989 38:1048-1055; doi:10.2337/diabetes.38.8.1048

  5. Triban, C

    • Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes August 1989 38:1012-1022; doi:10.2337/diabetes.38.8.1012

V

  1. Vinson, J A

    • In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes August 1989 38:1036-1041; doi:10.2337/diabetes.38.8.1036

W

  1. Weik, H

    • Functional pancreatic beta-cell line from SV40 T-antigen transgenic mouse. Diabetes August 1989 38:1056-1062; doi:10.2337/diabetes.38.8.1056

Y

  1. Yorek, M A

    • Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells. Diabetes August 1989 38:996-1004; doi:10.2337/diabetes.38.8.996

Z

  1. Zhang, W X

    • Autonomic neuropathy in BB rats and alterations in bladder function. Diabetes August 1989 38:1023-1030; doi:10.2337/diabetes.38.8.1023

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement